Dr. Shahzad Siddique
Claim this profilePenrose-Saint Francis Healthcare
Expert in Cancer
Expert in Breast Cancer
100 reported clinical trials
168 drugs studied
About Shahzad Siddique
Education:
- Earned a Medical Degree (MD).
Experience:
- Served as Principal Investigator for the clinical trial "Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects."
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 positive
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Shahzad Siddique is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Cemiplimab + Palbociclib
for Liposarcoma
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Cemiplimab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. The combination of these two drugs may be more effective in shrinking or stabilizing advanced dedifferentiated liposarcoma compared to palbociclib alone.
Recruiting1 award Phase 2
More about Shahzad Siddique
Clinical Trial Related4 years of experience running clinical trials · Led 100 trials as a Principal Investigator · 77 Active Clinical TrialsTreatments Shahzad Siddique has experience with
- Nivolumab
- Carboplatin
- Cisplatin
- Paclitaxel
- Atezolizumab
- Pembrolizumab
Breakdown of trials Shahzad Siddique has run
Cancer
Breast Cancer
Tumors
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shahzad Siddique specialize in?
Shahzad Siddique focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Shahzad Siddique currently recruiting for clinical trials?
Yes, Shahzad Siddique is currently recruiting for 75 clinical trials in Colorado Springs Colorado. If you're interested in participating, you should apply.
Are there any treatments that Shahzad Siddique has studied deeply?
Yes, Shahzad Siddique has studied treatments such as Nivolumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Shahzad Siddique?
Apply for one of the trials that Shahzad Siddique is conducting.
What is the office address of Shahzad Siddique?
The office of Shahzad Siddique is located at: Penrose-Saint Francis Healthcare, Colorado Springs, Colorado 80907 United States. This is the address for their practice at the Penrose-Saint Francis Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.